STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS

被引：0
|
作者：
Lagerwaard, Frank J. [1 ]
Verstegen, Naomi E. [1 ]
Haasbeek, Cornelis J. [1 ]
Slotman, Ben [1 ]
Paul, M. A. [2 ]
Smit, Egbert F. [3 ]
Senan, Suresh [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Stage I non-small cell lung cancer; Operable; Stereotactic ablative radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S278 / S279
页数：2
相关论文
共 50 条
  • [31] Feasibility of Stereotactic Ablative Radiotherapy (SABR) for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)
    Woodford, Katrina
    Panettieri, Vanessa
    Trieumy Tran Le
    Senthi, Sashendra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1467 - S1468
  • [32] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [33] Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Sanuki, Naoko
    Tsurugai, Yuichiro
    Aoki, Yousuke
    Oku, Yohei
    Hara, Yu
    Akiba, Takeshi
    Shigematsu, Naoyuki
    LUNG CANCER, 2017, 109 : 62 - 67
  • [34] The optimal treatment for patients with stage I non-small cell lung cancer: Minimally invasive lobectomy or stereotactic ablative radiotherapy?
    de Ruiter, J.
    van der Noort, V.
    van Diessen, J.
    Smit, E. F.
    Damhuis, R.
    Hartemink, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S98 - S98
  • [35] Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
    Mirimanoff, Rene-Olivier
    CHINESE CLINICAL ONCOLOGY, 2015, 4 (04)
  • [36] Pulmonary Function Changes After Stereotactic Ablative Radiotherapy In 201 Patients With Stage I Non-small Cell Lung Cancer
    Senan, S.
    Phernambucq, E. C. J.
    van de Ven, P. M.
    Groepenhoff, H.
    Postmus, P. E.
    Slotman, B. J.
    Smit, E. F.
    Lagerwaard, F. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S579 - S579
  • [37] Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
    Abel, Stephen
    Hasan, Shaakir
    White, Richard
    Schumacher, Lana
    Finley, Gene
    Colonias, Athanasios
    Wegner, Rodney E.
    LUNG CANCER, 2019, 128 : 127 - 133
  • [38] QUANTIFYING PULMONARY FUNCTION CHANGES AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR STAGE I NON-SMALL-CELL LUNG CANCER
    Phernambucq, Erik C.
    Lagerwaard, Frank J.
    Van De Ven, Peter M.
    Groepenhoff, Herman
    Postmus, Pieter E.
    Slotman, Ben
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S385 - S386
  • [39] Treatment of Early Stage Non-Small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?
    Uzel, Esengul Kocak
    Abacioglu, Ufuk
    BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 8 - 16
  • [40] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution
    Varela, Gonzalo
    Teresa Gomez-Hernandez, Maria
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 102 - 105
12345